@Cshar thats quite an allocation conviction and patience in current market situations, would be good to hear your thoughts on future possibilities and performance for everyone’s benefit.
Also would you have some materials or pointers to better understand their US/Canada biz ( radiopharma, allegry etc) that you can share with this group.
On your point of WHO covaxin approval benefits - did you mean US and Canada sponsered LMIC countries related procurements? As most of citizens of developed countries are already vaccinated and even for booster shots they may incline towards Moderna or Pfizers, rather than an India originated vaccine.
Thanks.